Global Biomarker Technologies Market to Reach US$ 113.4 Billion by 2032, Driven by Increasing Focus on Personalized Medicines

June 23, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Biomarker Technologies Market Report by Test Type (Solid Biopsy, Liquid Biopsy), Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others), Product (Consumables, Assay, Reagent, Instruments), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others), Application (Drug Discovery, Clinical Diagnostics, Personalized Medicine), and Region 2024-2032,” the global biomarker technologies market size reached US$ 40.2 Billion in 2023. Biomarker technologies refer to the various methods and tools used to identify, measure, and analyze biomarkers in biological samples. Biomarkers are measurable indicators, such as molecules or genetic changes, that provide information about biological processes, disease presence, or treatment responses. The goal of biomarker technologies is to improve disease detection, optimize treatment outcomes, and enhance patient care by providing objective and quantifiable measures of biological processes. They have applications across various fields, including clinical medicine, pharmaceuticals, diagnostics, and research, contributing to advancements in healthcare and precision medicine. Biomarker technologies encompass a wide range of techniques and platforms, including genomics, proteomics, metabolomics, imaging, immunoassays, and molecular diagnostics. These technologies enable the discovery, validation, and application of biomarkers for various purposes, such as disease diagnosis, prognosis, monitoring, and drug development. These technologies involve the use of advanced laboratory equipment, bioinformatics tools, and data analysis techniques to identify and measure specific biomolecules or genetic alterations associated with diseases or physiological changes. Biomarker technologies play a critical role in personalized medicine by aiding in patient stratification, treatment selection, and monitoring of therapeutic efficacy.

Global Biomarker Technologies Market Trends:

The rising demand for personalized medicines represents one of the key factors driving the growth of the market across the globe. This, coupled with the increasing focus on personalized healthcare and targeted therapies and enabling the identification and monitoring of specific biological indicators associated with diseases or treatment responses, is acting as a growth-inducing factor. The market is also driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, diabetes, and neurological conditions, which is creating a need for effective diagnostic and prognostic tools. In line with this, biomarker technologies offering the potential to detect diseases at early stages, predict patient outcomes, and guide treatment decisions, are contributing to the growth of the market. In addition to this, the rising shift toward non-invasive or minimally diagnostic approaches, along with the increasing awareness regarding non-invasive biomarker tests, such as liquid biopsies or breath tests, are facilitating the growth of the market. Apart from this, significant technological advancements in biomarker technologies, such as high-throughput screening methods, next-generation sequencing, mass spectrometry, and digital imaging, are boosting the growth of the market. These advancements enhance sensitivity, specificity, and the ability to analyze multiple biomarkers simultaneously, thus driving the market growth. Moreover, rapid advancements in genomics, proteomics, and other omics technologies, the increasing research and development (R&D) activities, the rising focus on discovering novel biomarkers and validating their clinical utility, increasing geriatric population, and favorable regulatory frameworks and reimbursement policies for biomarker-based diagnostics and companion diagnostics, are some of the other factors creating a positive outlook for the market across the globe. Looking forward, the market value is projected to reach US$ 113.4 Billion by 2032, expanding at a CAGR of 11.8% during 2024-2032.

Market Summary:

  • Based on test type, the market has been classified into solid biopsy and liquid biopsy. Currently, liquid biopsy holds the largest market share worldwide.
  • On the basis of indication, the market has been segmented into cancer, infectious diseases, autoimmune disorders, cardiovascular disorders, and others. Currently, cancer is dominating the market across the globe.
  • Based on product, the market has been segregated into consumables, assay, reagent, and instruments. Presently, consumables is holding the largest market share worldwide.
  • On the basis of technology, the market has been segmented into polymerase chain reaction (PCR), next generation sequencing (NGS), immunoassay, and others. Currently, immunoassay is dominating the market across the globe.
  • Based on application, the market has been segregated into drug discovery, clinical diagnostics, and personalized medicine. Presently, drug discovery is holding the largest market share worldwide.
  • On a geographical front, the market has been segmented into Asia Pacific, North America, Europe, Middle East and Africa, and Latin America. Presently, North America is dominating the market across the world.
  • The competitive landscape of the market has also been examined with some of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Test Type, Indication, Product, Technology, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Biomarker Technologies Market to Reach US$ 113.4 Billion by 2032, Driven by Increasing Focus on Personalized Medicines
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More